Huntsman Carole 4

What Happened

• Carole Huntsman, Chief Commercial Officer of Madrigal Pharmaceuticals (MDGL), sold a total of 910 shares in two open-market transactions on January 26, 2026, generating gross proceeds of approximately $449,339. The sales were: 340 shares at $492.42 ($167,423) and 570 shares at $494.59 ($281,916). These were sales (not purchases) and sales by insiders are often routine.

Key Details

• Transaction dates and prices:
  • 2026-01-26: 340 shares sold at $492.42 — $167,423 (Footnote F1)
  • 2026-01-26: 570 shares sold at $494.59 — $281,916 (Footnote F2)
• Combined total: 910 shares for ~$449,339.
• Shares owned after transaction: Not reported in the provided Form 4 excerpt.
• Footnotes:
  • F1: The 340-share sale was an automatic sale by the issuer to cover tax withholding on vested restricted stock units (not at the Reporting Person’s discretion).
  • F2: The 570-share sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on Nov 5, 2024.
• Filing timeliness: No indication in the provided data that the filing was late.

Context

• These transactions include a tax-withholding disposition and a planned sale under a 10b5-1 plan. Such sales are commonly procedural and do not, by themselves, indicate the insider’s view of the company’s prospects.